All In Biotech

Drug Trial Radar · NCT00666185

Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis

A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis

Last checked: Nov 19, 2026Latest source record: Sep 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 523 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

523

Actual

Start

Aug 2003

Primary completion

Feb 2004

Study completion Feb 2004

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
First posted
Apr 24, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the efficacy and safety of IV Micafungin versus IV Fluconazole in the treatment of patients with Esophageal Candidiasis

Conditions

  • Candidiasis, Oral

Interventions

  • MicafunginDrug

    IV

  • FluconazoleDrug

    IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Endoscopic cure rate, defined as a mucosal grade of zero at the end of the therapyTime frame: End of Therapy

Locations

37 sites in 3 countries. Site status is shown where the registry gives one.

  • Site not named

    Abadia Uberaba, Brazil

  • Site not named

    Barretos, Brazil

  • 5 Sites

    Belo Horizonte, Brazil

  • Site not named

    Boqueirao - Santos, Brazil

  • 2 Sites

    Campinas, Brazil

  • 2 Sites

    Curitiba, Brazil

  • Site not named

    Goiânia, Brazil

  • Site not named

    Maruipe Victoria, Brazil

  • Site not named

    Nova Iguaçu, Brazil

  • Site not named

    Parquelandia - Fortaleza, Brazil

  • Site not named

    Porto Alegre, Brazil

  • Site not named

    Quinta - Natal, Brazil

  • 4 Sites

    Rio de Janeiro, Brazil

  • 2 Sites

    Salvador, Brazil

  • Site not named

    São José do Rio Preto, Brazil

  • 8 Sites

    São Paulo, Brazil

  • 4 Sites

    Lima, Peru

  • Site not named

    Arcadia-Pretoria, South Africa

  • Site not named

    Bellville - Cape Town, South Africa

  • 2 Sites

    Bloemfontein, South Africa

  • Site not named

    Brits, South Africa

  • Site not named

    Cape Town, South Africa

  • Site not named

    Centurion, South Africa

  • Site not named

    Dundee, South Africa

  • 2 Sites

    Durban, South Africa

  • Site not named

    Hatfield - Pretoria, South Africa

  • Site not named

    Johannesburg, South Africa

  • Site not named

    Olifantsfontein, South Africa

  • Site not named

    Paarl, South Africa

  • 2 Sites

    Port Elizabeth, South Africa

  • Site not named

    Potchefstroom, South Africa

  • 3 Sites

    Pretoria, South Africa

  • Site not named

    Pretoria West, South Africa

  • Site not named

    Reiger Park, South Africa

  • Site not named

    Richards Bay, South Africa

  • Site not named

    Somerset West, South Africa

  • Site not named

    Westdene - Bloemfontein, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.